高级检索
当前位置: 首页 > 详情页

LC-MS/MS-based metabolomic profiling identifies candidate biomarkers in follicular fluid of infertile women with chronic pelvic inflammatory disease

| 认领 | 导出 |

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Reproductive Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510095, Guangdong, P. R. China. [2]Department of Dermatology, Guangzhou Institute of Dermatology Guangzhou 510095, Guangdong, P. R. China.
出处:

关键词: Biomarker follicular fluid infertility LC-MS metabolic profiles

摘要:
How chronic pelvic inflammatory disease (CPID), the most common cause of infertility, affects metabolic profiles of follicular fluid (FF) remains unknown. This study aimed to identify candidate biomarkers in FF of infertile women with CPID.FF samples were collected from infertile women with CPID (n = 8) and healthy controls (n = 8) at the time of oocyte retrieval. Untargeted metabolomic profiling of FF samples was conducted using the liquid chromatography-tandem mass spectrometry (LC-MS/MS).A total of 240 differential metabolites (104 named biochemicals and 136 unnamed biochemicals) were screened out and identified. Among them, pregnane-3,3-diol, pc(p-18:1(11z)/18:3(6z,9z,12z)), and 1-octadecanoyl-2-(4z,7z,10z,13z,16z,19z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine were markedly down-regulated, while 17,21-dihydroxypregnenolone was significantly up-regulated in infertile women with CPID. Furthermore, KEGG biological pathway analysis revealed that these metabolites were especially enriched in steroid hormone biosynthesis, glyoxylate and dicarboxylate metabolism, glucagon signaling pathway, and the tricarboxylic acid (TCA) cycle.FF of infertile women with CPID showed unique metabolic changes that may be involved in the pathogenesis of infertility and serve as new therapeutic targets or diagnostic biomarkers.IJCEP Copyright © 2023.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
第一作者:
第一作者机构: [1]Department of Reproductive Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510095, Guangdong, P. R. China.
通讯作者:
通讯机构: [1]Department of Reproductive Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510095, Guangdong, P. R. China. [2]Department of Dermatology, Guangzhou Institute of Dermatology Guangzhou 510095, Guangdong, P. R. China. [*1]Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou 510095, Guangdong, P. R. China. [*2]Department of Reproductive Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510095, Guangdong, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号